Looking for a Trusted Partner to Enter the Japanese Pharmaceutical Market?

Are you a biotech, pharma, API, CDMO/CMO, CRO, or regenerative medicine company in Asia-Oceania?

Companies from China, Korea, Taiwan, Singapore, India, Australia, and other regions are rapidly expanding their global business.
However, many face the same challenge when approaching Japan:

• “We don’t know how to enter the Japanese market.”

• “PMDA regulations are difficult to understand.”

• “Japanese business culture is unique.”

• “We need reliable local partners.”

• “Negotiations with Japanese companies move slowly.”

• “Quality expectations are much higher than expected.”

Japan is not simply another Asian market.

Success in Japan requires more than translation or regulatory knowledge.
It requires understanding of:

• Japanese quality culture

• GMP/GCTP expectations

• PMDA communication style

• Consensus-based decision making

• Long-term trust building

• Business practices based on implicit understanding

At Japan Pharma Business Supporters Association,
we help overseas companies bridge the gap between “regulations” and “real business operations” in Japan.

What We Support

Market Entry & Business Development

• Japanese market entry strategy

• Local partner matching

• Business development support

• Japanese company introductions

• Local business structure support

Regulatory & Quality Support

• PMDA strategy and communication

• GMP/GCTP/GQP/GVP support

• Japanese CTD preparation

• Quality system establishment

• Vendor qualification and audit support

Cross-Cultural Business Support

• Japanese negotiation support

• Technical communication support

• Understanding Japanese business customs

• Long-term partnership building

Target Areas

• Drug discovery startups

• Regenerative medicine

• Cell & gene therapy

• mRNA/LNP

• Nucleic acid therapeutics

• Biologics

• APIs

• CDMO/CMO

• CRO

• Exosome technologies

• Functional foods & cosmetics

Beyond “Drug Discovery Support”

We believe Japan needs more than conventional consulting.

We call our approach “Pharma Business Support” — connecting the vertical layers of the pharmaceutical ecosystem:

• R&D

• Regulatory

• Quality

• Manufacturing

• Investment

• Academia

• Business development

and weaving them together into practical business execution in Japan.

In Japan, success is determined not only by technology, but also by:

• who you work with,

• how you communicate,

• how quality is governed,

• and how trust is established.

Connecting Asia and Japan Through Pharma

Our mission is to connect the innovation emerging across Asia-Oceania with Japan’s strengths in:

• quality culture,

• regulatory reliability,

• manufacturing excellence,

• and long-term business infrastructure.

If you are looking for a trusted Japanese partner for your expansion strategy,
we would be happy to connect.

Registration and initial consultation are free.
Let’s start with a conversation.

#Japan
#Pharma
#Biotech
#CDMO
#CRO
#RegenerativeMedicine
#mRNA
#CellTherapy
#GeneTherapy
#PMDA
#GMP
#BusinessDevelopment
#Asia
#DrugDevelopment